MATURE B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for MATURE B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for MATURE B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost survival in kids with aggressive blood cancer
Disease control OngoingThis study tests whether adding 4 injections of rituximab to stronger chemotherapy can help children and teens with mature B-cell non-Hodgkin lymphoma or B-cell acute leukemia live longer without the cancer coming back. About 200 participants in China will receive the new regimen…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for kids with aggressive blood cancer: targeted therapy added to chemo
Disease control OngoingThis study tests whether adding the targeted drug rituximab to standard chemotherapy improves outcomes for children and teens with aggressive B-cell lymphoma or leukemia. About 650 participants across Europe will receive different treatment schedules to find the safest and most e…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated May 18, 2026 12:09 UTC